Bloomios, Inc. (BLMS)
Bloomios, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Santa Barbara, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $19,341. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -226.7%. Its beta of -0.43 implies it has historically moved less than the broad market.
Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. The company’s product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. It sells its hemp derived supplements and cosmetic products through wholesale and retail distribution channels. The company was formerly known as XLR Medical Corp. and changed its name to Bloomios, Inc. in April 2021. Bloomios, Inc. was incorporated in 2001 and is headquartered in Santa Barbara, California.
Bloomios, Inc. is most often compared with the following Healthcare names: